{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:58Z","timestamp":1790776378679,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cure for Cancer foundation"},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.urolonc.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T09:28:26Z","timestamp":1543570106000},"page":"183.e1-183.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-0483","authenticated-orcid":false,"given":"Mara","family":"Buijs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Zondervan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krijn P.","family":"van Lienden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto M.","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.11.008_bib0001","first-page":"7","article-title":"Cancer statistics 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0002","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0003","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0004","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.juro.2015.03.115","article-title":"Oncologic efficacy of radio frequency ablation for small renal masses: clear cell vs papillary subtype","volume":"194","author":"Lay","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jvir.2011.09.008","article-title":"Complications following 573 percutaneous renal radiofrequency and cryoablation procedures","volume":"23","author":"Atwell","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jvir.2006.12.007","article-title":"CT-guided percutaneous cryotherapy of renal masses","volume":"18","author":"Littrup","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0007","article-title":"Upper-urinary-tract effects after irreversible electroporation (IRE) of human localised renal-cell carcinoma (RCC) in the IRENE pilot phase 2a ablate-and-resect study","author":"Wendler","year":"2017","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0008","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00270-010-9964-1","article-title":"Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study","volume":"34","author":"Pech","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0009","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jvir.2016.03.044","article-title":"Irreversible electroporation for surgical renal masses in solitary kidneys: short-term interventional and functional outcome","volume":"27","author":"Diehl","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","article-title":"Investigation of the safety of irreversible electroporation in humans","volume":"22","author":"Thomson","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0011","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jvir.2015.06.028","article-title":"Minimally invasive percutaneous treatment of small renal tumors with irreversible electroporation: a single-center experience","volume":"26","author":"Trimmer","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0012","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2196\/resprot.6725","article-title":"Irreversible electroporation for the ablation of renal cell carcinoma: a prospective, human, in vivo study protocol (IDEAL phase 2b)","volume":"6","author":"Buijs","year":"2017","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0013","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0014","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/bja\/aeu256","article-title":"Anaesthetic management during open and percutaneous irreversible electroporation","volume":"113","author":"Nielsen","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0015","series-title":"Treatment of postoperative complications after digestive surgery","first-page":"13","article-title":"The Clavien\u2013Dindo classification of surgical complications","author":"Dindo","year":"2014"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0016","first-page":"0","article-title":"Common terminology criteria for adverse events (CTCAE)","volume":"2009","year":"2010","journal-title":"NIH Publ"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2011.10.033","article-title":"Guidelines on reporting and grading of complications after urologic surgical procedures","volume":"61(2)","author":"Mitropoulos","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2011.03.029","article-title":"Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL nephrometry score","volume":"60","author":"Kutikov","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.juro.2011.03.020","article-title":"Critical appraisal of the Padua classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy","volume":"186","author":"Hew","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","article-title":"Validity of Charlson comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS plus registry 2002-2012","volume":"100","author":"Radovanovic","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0022","article-title":"Partial nephrectomy versus thermal ablation for clinical stage t1 renal masses: systematic review and meta-analysis of more than 3,900 patients","author":"Rivero","year":"2017","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.urolonc.2018.11.008_bib0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0024","article-title":"First delayed resection findings after irreversible electroporation (IRE) of human localised renal cell carcinoma (RCC) in the IRENE pilot phase 2a trial","author":"Wendler","year":"2015","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.urolonc.2018.11.008_bib0025","first-page":"1","article-title":"Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series","author":"Canvasser","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0026","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1569-9056(17)30129-X","article-title":"Initial assessment of clinical feasibility, safety and efficacy of NanoKnife irreversible electroporation (IRE) in the focal treatment of localized renal cell carcinoma (RCC) with delayed interval tumor resection (IRENE trial)","volume":"16","author":"Wendler","year":"2017","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.urolonc.2018.11.008_bib0027","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","article-title":"Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma","volume":"63","author":"Psutka","year":"2013","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830454X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830454X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:14:42Z","timestamp":1761041682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391830454X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S107814391830454X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.11.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}